Dr. Yanjie Lu, M.D, Ph.D., a professor at Harbin Medical University in China and a world-renowned expert on myocardial infarction has published a study in STEM CELLS Translational Medicine on mesenchymal stem cells (MSCs) and their potential to protect the heart from further damage after a cardiac incident. The study, which involved studying rats who had been injected with MSCs, could promote stem cells as a potential treatment for heart conditions. Not only does the study show that MSCs can protect the heart from further damage, but the study also concluded that MSCs have the potential to slow down the heart’s aging process. Dr. Lu said of the study,“Our study didn’t just unravel the efficacy of MSCs in fighting cardiac aging, it also delineated the mechanisms underlying this beneficial action.”
To view the entire article, click here.
The post Study Showing How Stem Cells Slow Aging May Lead to New Heart Failure Treatments appeared first on Celltex Therapeutics.